Mpox Vaccination | Mpox | CDC JYNNEOS is a 2-dose vaccine developed to protect against mpox and smallpox Getting both recommended doses of the vaccine provides the best protection against mpox
Package-Insert-JYNNEOS - U. S. Food and Drug Administration JYNNEOS is a vaccine indicated for prevention of smallpox and monkeypox disease in adults 18 years of age and older determined to be at high risk for smallpox or monkeypox infection
JYNNEOS Vaccine for Mpox: Frequently Asked Questions - NYC. gov The JYNNEOS vaccine is approved for the prevention of mpox and smallpox The vaccine contains vaccinia virus, a virus related to the mpox and smallpox viruses, that has been weakened, cannot copy itself in human cells, and cannot spread to other parts of the body or people
JYNNEOS—Frequently Asked Questions Key Poin • The FDA has authorized the emergency use of JYNNEOS to be given as an injection beneath the skin (subcutaneously) for people younger than 18 years of age The changes will help make the vaccine available to more people, promote equitable access, and help to prevent the spread of monkeypox (hMPXV)
Smallpox Monkeypox Vaccine (JYNNEOS™): What You Need to Know JYNNEOS™ is approved by the Food and Drug Administration (FDA) for prevention of smallpox and monkeypox disease in adults 18 years or older at high risk for smallpox or monkeypox infection
Vaccine for Mpox Prevention in the United States | Mpox | CDC People may be vaccinated after exposure to MPXV to help prevent mpox (i e , post-exposure prophylaxis) Two vaccines may be used for the prevention of mpox: JYNNEOS vaccine is approved and recommended by CDC and ACIP for the prevention of mpox and smallpox